| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Dillione Janet | Director | C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS | /s/ Janet Dillione | 26 Nov 2025 | 0001489798 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRMD | Common Stock | Options Exercise | $22,800 | +8,000 | +17% | $2.85 | 56,473 | 24 Nov 2025 | Direct | |
| transaction | CRMD | Common Stock | Options Exercise | $31,394 | +7,790 | +14% | $4.03 | 64,263 | 24 Nov 2025 | Direct | |
| transaction | CRMD | Common Stock | Options Exercise | $21,601 | +4,876 | +7.6% | $4.43 | 69,139 | 24 Nov 2025 | Direct | |
| transaction | CRMD | Common Stock | Options Exercise | $20,153 | +5,677 | +8.2% | $3.55 | 74,816 | 24 Nov 2025 | Direct | |
| transaction | CRMD | Common Stock | Sale | $261,586 | -26,343 | -35% | $9.93 | 48,473 | 24 Nov 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -8,000 | -100% | $0.000000 | 0 | 24 Nov 2025 | Common Stock | 8,000 | $2.85 | Direct | F2 |
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -7,790 | -39% | $0.000000 | 12,210 | 24 Nov 2025 | Common Stock | 7,790 | $4.03 | Direct | F3 |
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -4,876 | -24% | $0.000000 | 15,124 | 24 Nov 2025 | Common Stock | 4,876 | $4.43 | Direct | F4 |
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -5,677 | -19% | $0.000000 | 24,323 | 24 Nov 2025 | Common Stock | 5,677 | $3.55 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $9.72 to $10.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F2 | These options were granted on 02/16/2018. These options are fully vested. |
| F3 | These options were granted on 02/22/2022. These options are fully vested. |
| F4 | These options were granted on 01/14/2023. These options are fully vested. |
| F5 | These options were granted on 03/05/2024. These options are fully vested. |